Our results with recombinant murine GM-CSF also revealed that while the total level of tumor-infiltrating DCs and CD8+ T-cells was increased, neither DC maturation nor T-cell activation was enhanced (Figs 3A, 3B, 5A and 5C). The gene discussed is CD8A; the disease is neoplasm.